Century Therapeutics, Inc. (IPSC)
NASDAQ: IPSC · Real-Time Price · USD
0.5588
-0.0154 (-2.68%)
At close: May 23, 2025, 4:00 PM
0.5600
+0.0012 (0.21%)
After-hours: May 23, 2025, 7:56 PM EDT

Century Therapeutics Balance Sheet

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
TTM FY 2024 FY 2023 FY 2022 FY 2021 FY 2020 2019
Period Ending
Mar '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 2019
Cash & Equivalents
51.8758.4447.3284.2756.4527.21
Upgrade
Short-Term Investments
113.26130.85125.41231.23166.4348.54
Upgrade
Cash & Short-Term Investments
165.12189.29172.74315.5222.8875.75
Upgrade
Cash Growth
-14.01%9.58%-45.25%41.56%194.22%-7.10%
Upgrade
Other Receivables
0.981.522.240.780.250.91
Upgrade
Receivables
0.981.522.240.780.250.91
Upgrade
Prepaid Expenses
3.531.530.761.451.61-
Upgrade
Other Current Assets
-1.711.261.993.422.14
Upgrade
Total Current Assets
169.63194.05176.99319.72228.1578.8
Upgrade
Property, Plant & Equipment
87.7690.8592.08111.7369.8224.78
Upgrade
Long-Term Investments
20.7130.8289.151.85135.911.05
Upgrade
Other Intangible Assets
34.234.2----
Upgrade
Other Long-Term Assets
3.33.32.523.243.492.15
Upgrade
Total Assets
315.61353.22360.69486.54437.38106.78
Upgrade
Accounts Payable
3.573.082.745.457.68.08
Upgrade
Accrued Expenses
6.0512.598.649.375.433.79
Upgrade
Current Portion of Long-Term Debt
---6.51.04-
Upgrade
Current Portion of Leases
4.884.871.510.480.620.24
Upgrade
Current Unearned Revenue
-109.164.377.15--
Upgrade
Other Current Liabilities
-0.080.580.870.98-
Upgrade
Total Current Liabilities
14.5129.7817.8529.8215.6612.11
Upgrade
Long-Term Debt
---3.748.99.64
Upgrade
Long-Term Leases
47.7948.9646.6638.714.5611.68
Upgrade
Long-Term Unearned Revenue
--111.38110.83--
Upgrade
Long-Term Deferred Tax Liabilities
4.374.37----
Upgrade
Other Long-Term Liabilities
8.58.740.060.722.02-
Upgrade
Total Liabilities
75.17191.85175.94183.8141.1433.43
Upgrade
Common Stock
0.010.010.010.010.010
Upgrade
Additional Paid-In Capital
945.9943.37840.41824.29785.05217.83
Upgrade
Retained Earnings
-705.78-782.34-655.77-519.1-388.17-292.34
Upgrade
Comprehensive Income & Other
0.310.320.11-2.46-0.65-31.9
Upgrade
Total Common Equity
240.44161.36184.75302.74396.24-106.41
Upgrade
Shareholders' Equity
240.44161.36184.75302.74396.2473.35
Upgrade
Total Liabilities & Equity
315.61353.22360.69486.54437.38106.78
Upgrade
Total Debt
52.6853.8348.1749.4125.1221.56
Upgrade
Net Cash (Debt)
112.45135.46124.57266.08197.7654.2
Upgrade
Net Cash Growth
-22.74%8.75%-53.19%34.55%264.89%-33.53%
Upgrade
Net Cash Per Share
1.331.722.104.616.117.24
Upgrade
Filing Date Shares Outstanding
86.1686.0564.8259.1758.827.84
Upgrade
Total Common Shares Outstanding
86.1585.8460.3458.4755.017.48
Upgrade
Working Capital
155.1364.27159.15289.9212.566.69
Upgrade
Book Value Per Share
2.791.883.065.187.20-14.22
Upgrade
Tangible Book Value
206.24127.16184.75302.74396.24-106.41
Upgrade
Tangible Book Value Per Share
2.391.483.065.187.20-14.22
Upgrade
Machinery
33.7833.6130.6630.3619.479.02
Upgrade
Construction In Progress
0.330.10.121432.845.77
Upgrade
Leasehold Improvements
61.6261.5860.8648.958.371.96
Upgrade
Updated Mar 19, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.
SEC Filings: 10-K · 10-Q